Patent details

EP3103861 Title: VIRUS FILTRATION OF CELL CULTURE MEDIA

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3103861
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16181886.9
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
13/06/2013
Grant date:
30/09/2020
EP Publication Date:
14/12/2016
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
03/11/2020
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
30/09/2020
EP B1 Publication Date:
30/09/2020
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
12/06/2033
Lapsed By Expiration Date:
Patent Validated Date:
27/11/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
24/03/2023
 
 

 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka, Japan (JP)

Historical Applicant/holder

From:
30/09/2020
To:
24/03/2023

 

Name:
Baxalta GmbH
Address:
Thurgauerstrasse 130, 8152 Glattpark (Opfikon), Switzerland (CH)

From:
30/09/2020
To:
24/03/2023

 

Name:
Baxalta Incorporated
Address:
1200 Lakeside Drive, 60015, Bannockburn, Illinois, United States of America (US)

Agent

1

Name:
dr. ir. F.M. van Bouwelen
From:
24/03/2023
Address:
Hoffmann Eitle B.V. Weerdestein 97, 1083 GG, AMSTERDAM, Netherlands (NL)
To:

2

Name:
mr.ir. F.N. Ferro
From:
18/11/2020
Address:
Hoffmann Eitle B.V. Strawinskylaan 3051 4th Floor, 1077 ZX, AMSTERDAM, Netherlands (NL)
To:
24/03/2023

Inventor

1

Name:
MUNDT, Wolfgang
Address:
A-1080 Vienna, Austria (AT)

2

Name:
MITTERER, Artur
Address:
A-2304 Orth/Donau, Austria (AT)

3

Name:
REITER, Manfred
Address:
A-1150 Vienna, Austria (AT)

4

Name:
HASSLACHER, Meinhard
Address:
A-1020 Vienna, Austria (AT)

5

Name:
GRILLBERGER, Leopold
Address:
Winchester MA 01890, United States of America (US)

6

Name:
KREIL, Thomas
Address:
A-3400 Klosterneuburg, Austria (AT)

Priority

Priority Patent Number:
201261662814 P
Priority Date:
21/06/2012
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61L 2/00; C12M 1/00; C12M 1/12; C12N 5/00;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
14/23
Publication date:
05/04/2023
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
49/20
Publication date:
02/12/2020
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
40/20
Publication date:
30/09/2020
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202040
Publication date:
30/09/2020
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202300633A
Date Registered:
24/03/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. ir. F.M. van Bouwelen
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka, Japan (JP)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/06/2025
Annual Fee Number:
13
Annual Fee Amount:
700 Euro
Last Annual Payment Date:
21/05/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
600 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
26/11/2020 Outgoing Correspondence Letter no formal defects 1 PDF /0/6/7/5/0/0800605760/docs/ep16181886.9_1_380831l271.pdf
03/11/2020 Claims First filed claims 3 PDF /0/6/7/5/0/0800605760/docs/ep16181886.9_0_claims20201109165550244.pdf